SIIC Salud





Ayuda
 

Comprar este informe
Extensión: 4.97 páginas impresas en papel A4 páginas impresas en papel A4

file05.gif (1491 bytes)
Art�culos seleccionados para su compra

Casos clínicos

LAS CARDIOPATIAS CONGENITAS ASOCIADAS A DUCTUS PERSISTENTE PUEDEN TRATARSE CON STENT

Las cardiopatías congénitas asociadas a ductus persistente pueden tratarse mediante la colocación de un stent en el conducto, como puente para la corrección quirúrgica total, de manera efectiva, lo que disminuye la mortalidad temprana.
Autor
Martha Alicia Hernández-González
Columnista Experto de SIIC
Institución del autor
Instituto Mexicano del Seguro Social, León, México

Artículos publicados por Martha Alicia Hernández-González
Coautores
Blanca Olivia Murillo-Ortíz* Sergio Solorio** Raúl Mendoza-Gómez*** Norma Amador-Licona**** Juan Manuel Guízar-Mendoza*****   
Doctora en Ciencias Médicas, Instituto Mexicano del Seguro Social, León, México*
Doctor en Ciencias Médicas. Cardiólogo Intervencionista., Instituto Mexicano del Seguro Social, León, México**
Cardiólogo Intervencionista, Instituto Mexicano del Seguro Social, León, México***
Doctora en Medicina. Medicina Interna, Instituto Mexicano del Seguro Social, León, México****
Doctor en Ciencias Médicas. Nefrólogo Pediatra., Instituto Mexicano del Seguro Social, León, México*****

link.gif
Profundizar versión original

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página  http://siicsalud.com/dato/casiic.php/101170

Especialidades
 rarrowsm.gif C.gif flecha_roja.gif   flecha_roja.gif 
Primera edición en siicsalud
26 de mayo, 2009

Bibliografía del caso clínico
1. Tálosi G, Katona M, Rácz K, Kertész E, Onozó B, Túri S. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects. J Perinat Med 32:368-74, 2004.
2. Hoch B, Bernhard M. Central apnoea and endogenous prostaglandins in neonates. Acta Paediatr 89:1364-8, 2000.
3. Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893-898, 1981.
4. Patel VV, Hasan RA, McLaughlin E. False aneurysm of the modified Blalock-Taussig shunt mimicking pulmonary disease in an infant. Clin Pediatr (Phila) 41(8):617-9, 2002.
5. Yoshimura N, Yamaguchi M, Oshima Y, Oka S, Ootaki Y, Tei T. Cerebral infarction in children due to thromboembolism from ligated Blalock-Taussig shunt. J Thorac Cardiovasc Surg 120:185-186, 2000.
6. Agnoletti G, Boudjemline Y, Bonnet D, Sidi D, Vouhé P. Surgical reconstruction of occluded pulmonary arteries in patients with congenital heart disease: effects on pulmonary artery growth. Circulation 109:2314-8, 2004.
7. Ruiz CE, Bailey LL. Stenting the ductus arteriosus: A "wanna-be" Blalock-Taussig. Circulation 99:2608-9, 1999.
8. Gibbs JL, Uzun O, Blackburn ME, Wren C, Hamilton JR, Watterson KG. Fate of the stented arterial duct. Circulation 99:2621-5, 1999.
9. Fesslova V, Nava S, Villa L, and the Fetal Cardiology Study Group of the Italian Society of Pediatric Cardiology. Evolution and long term outcome in cases with fetal diagnosis of congenital heart disease: Italian multicentre study. Heart 82:594-599, 1999.
10. Todros T. Prenatal diagnosis and management of fetal cardiovascular malformations. Curr Opin Obstet Gynecol 12:105-109, 2000.
11. Kecskes Z, Cartwright DW. Poor outcome of very low birthweight babies with serious congenital heart disease. Arch Dis Child Fetal Neonatal Ed 87:F31-3, 2002.
12. Dees E, Lin H, Cotton RB, Graham TP, Dodd DA. Outcome of preterm infants with congenital heart disease. J Pediatr 137:653-9, 2000.
13. Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol 28:91-136, 2001.
14. Gutgesell HP, Massaro TA. Management of hypoplastic left heart syndrome in a consortium of university hospitals. Am J Cardiol 76:809-11, 1995.
15. Jenkins PC, Flanagan MF, Jenkins KJ, et al. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol 36:1178-85, 2000.
16. Griselli M, McGuirk SP, Stümper O, et al. Influence of surgical strategies on outcome after the Norwood procedure. J Thorac Cardiovasc Surg 131:418-26, 2006.
17. Hehrlein FW, Yamamoto T, Orime Y, Bauer J. Hypoplastic left heart syndrome: "Which is the best operative strategy?". Ann Thorac Cardiovasc Surg 4:125-32, 1998.
18. Lim DS, Peeler BB, Matherne GP, Kron IL, Gutgesell HP. Risk-stratified approach to hybrid transcatheter-surgical palliation of hypoplastic left heart syndrome. Pediatr Cardiol 27:91-5, 2006.
19. Gibbs JL, Rothman MT, Rees MR, Parsons JM, Blackburn ME, Ruiz CE. Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J 67:240-5, 1992.
20. Michel-Behnke I, Akintuerk H, Thul J, Bauer J, Hagel KJ, Schranz D. Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease. Catheter Cardiovasc Interv 61:242-52, 2004.
21. Gewillig M, Boshoff DE, Dens J, Mertens L, Benson LN. Stenting the neonatal arterial duct in duct-dependent pulmonary circulation: new techniques, better results. J Am Coll Cardiol 43:107-12, 2004.
22. Michel-Behnke I, Akintuerk H, Marquardt I, et al. Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart 89:645-50, 2003.
23. Mitchell MB, Campbell DN, Boucek MM, et al. Mechanical limitation of pulmonary blood flow facilitates heart transplantation in older infants with hypoplastic left heart syndrome. Eur J Cardiothorac Surg 23:735-42, 2003.
24. Galantowicz M, Cheatham JP. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 26:190-9, 2005.
25. Tchervenkov Ch, Tahta SA, Jutras LC, Béland MJ. Biventricular repair in neonates with hypoplastic left heart complex. Ann Thorac Surg 66:1350-1357, 1998.
26. Weber R, Berger C, Balmer C, et al. Interventions using foreign material to treat congenital heart disease in children increase the risk for infective endocarditis. Pediatr Infect Dis 27:544-50, 2008.
27. Boshoff DE, Bethuyne N, Gewillig M, et al. Endovascular stenting of juvenile vessels: consequence of surgical stent removal on vessel architecture. Eur Heart J 28:1033-6, 2007.
28. Hernández-González M, Solorio S, Martínez-Sánchez A, et al. Stenting and redilatation of the ductus arteriosus in univentricular heart with pulmonary atresia. A case report. Arch Cardiol Mex 72:145-8, 2002.
29. Van Gameren M, Witsenburg M, Takkenberg JJ, et al. Early complications of stenting in patients with congenital heart disease: a multicentre study. Eur Heart J 27:2709-15, 2006.
30. Mendelsohn AM, Dorostkar PC, Moorehead CP, et al. Stent redilation in canine models of congenital heart disease: Pulmonary artery stenosis and coarctation of the aorta. Cathet Cardiovasc Diagn 38:430-440, 1996.
31. Okubo M, Benson LN. Intravascular and intracardiac stents used in congenital heart disease. Curr Opin Cardiol 16:84-91, 2001.
32. McMahon CJ, El-Said HG, Grifka RG, Fraley JK, Nihill MR, Mullins CE. Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol 38:521-6, 2001.
33. Santoro G, Gaio G, Palladino MT, et al. Stenting of the arterial duct in newborns with duct-dependent pulmonary circulation. Heart 94:925-929, 2008.
34. Ing FF, Grifka RG, Nihill MR, Mullins CE. Repeat dilation of intravascular stents in congenital heart defects. Circulation 92:893-7, 1995.
35. Alt E, Haehnel I, Beilharz C, et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 101:1453-8, 2000.
36. Schulz C, Niederer C, Andres C, et al. Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis model. Circulation 101:1970-5, 2000.
37. Albiero R, Nishida T, Adamian M, Amato A, et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 101:2454-7, 2000.
38. Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101:2165-71, 2000.
 
Artículos publicados por el autor (selección)
Oviedo López A, López Valenzuela P, Martínez Hernández R, Galván R, Solorio S, Hernández-González MA. Revascularization surgery through left off-pump thoracotomy is a viable alternative for coronary bypass re-operation Archivos de Cardiología de México 73(73):299-304, 2008

Hernández-González MA, Solorio S, Luna-Quintero C, Araiza-Guerra A, Cruz-Cervantes R, Luna-Ramírez S, Murillo-Ortiz B, Cruz-Márquez-Rico LM. Factors associated to major bleeding during heart surgery with cardiopulmonary bypass Archivos de Cardiología de México 78(78):273-278, 2008

Meave A, Alexanderson E, Hernández-González MA, Siu S, Soto ME, Solorio S, Espínola-Zavaleta N. Pure aortic stenosis and magnetic resonance in adult patients Archivos de Cardiología de México 77(77):308-312, 2007

Hernández-González M, Espínola-Zavaleta N, Solorio S, Malacara-Hernández JM, Jarquín VM, Díaz de León V, López-Valenzuela P. Cardiovascular magnetic resonance evaluation of left-to-right shunts due to cardiac septal defects in patients with pulmonary arterial hypertension Revista Española de Cardiología. 60(60):907-913, 2007

Solorio S, Hernández-González M, Rangel-Abundis A, Murillo-Ortiz B. Coronary artery disease in Mexican women Archivos de Cardiología de México. 77(77):226-231, 2007

Hernández-González M, Jiménez-Arteaga S, Ortega F, Solorio S, Martínez-Flores E, David-Gómez F, Sánchez-Soberanis A, y col. Pentalogía de Cantrell. A propósito de un caso Archivos de Cardiología de México 76(76):202-207, 2006

Meave-González A, Hernández-González M, Alexanderson-Rosas E, Vázquez-Antona C, Ermenger-Orellana J, Solorio-Meza S. Diagnosis of complex congenital heart disease through magnetic resonance Archivos de Cardiología de México. 75(75):435-440, 2005

Alva C, Sánchez A, Jiménez S, David F, Ortegón J, Hernández M. Congenital percutaneous aortic valvuloplasty in 70 subjects with congenital aortic stenosis, mid-term results Gaceta Médica de México 140(140):269-272, 2004

Alva C, David F, Hernández M, Argüero R, Ortegón J, Martínez A. Tricuspid atresia associated with common arterial trunk and 22q11 chromosome delection Archivos de Cardiología de México 73(73):271-274, 2004

Hernández-González M, Solorio S, Conde-Carmona I, Rangel-Abundis A, Ledesma M, Munayer J. Intraluminal aortoplasty vs. surgical aortic resection in congenital aortic coarctation. A clinical random study in pediatric patients Archives of Medical Research. 34(34):305-310, 2003

Juárez-Rodríguez M, Alva-Espinosa C, Ledesma-Velazco M, Lazala-Rodríguez G, Jiménez-Arteaga S, Sánchez-Soberanis A, Ortegón Cerdeña J, David Gómez F, Hernández-González M. Valvuloplastía pulmonar con balón. Experiencia de 15 años en el Centro Medico Nacional Siglo XXI IMSS. Archivos de Cardiología de México 73(73):190-196, 2003

Alva C, Ortegón J, Herrera F, Meléndez C, David F, Jiménez S, Jiménez D, Sánchez A, Hernández M. Types of obstructions in double-chambered right ventricle: mid-terms results Archives of Medical Research. 33(33):261-264, 2002

Alva C, Sánchez A, David F, Jiménez S, Jiménez D, Ortegón J, Hernández M. Percutaneous aortic valvoplasty in congenital aortic valves stenosis Cardiology in the Young 12(12):328-332, 2002

Rangel A, Albarrán H, Solorio S, Hernández-González MA. Angiographic concurrente of coronary artery disease and aortoiliac lesions Angiology 53(53):685-692, 2002

Hernández-González MA, Alva-Espinosa C, Martínez-Sánchez A. Transposición corregida de las grandes arterias. Incidencia y presentación clínica Revista Mexicana de Cardiología. 8(8):25-29, 1997

Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.

anterior.gif (1015 bytes)


Suscripción a siicsalud


Bienvenidos a siicsalud

Acerca de SIIC     Estructura de SIIC

Sociedad Iberoamericana de Información Científica (SIIC)
Av. Belgrano 430, (C1092AAR), ciudad de Buenos Aires, Argentina
Tel: +54 11 4342 4901
Casilla de Correo 2568, (C1000WAZ) Correo Central, ciudad de Buenos Aires
Copyright siicsalud© 1997-2017, Sociedad  Iberoamericana de Información Científica (SIIC)
ISSN siicsalud: 1667-9008
ua4711
Mensajes a SIIC